• Explore /
  • Poster
  • / Subcutaneous delivery of amivantamab in patients with advanced solid malignancies: PALOMA, an open-label, multicenter, dose escalation phase 1b study.

Subcutaneous delivery of amivantamab in patients with advanced solid malignancies: PALOMA, an open-label, multicenter, dose escalation phase 1b study.

Abstract Video & Slides Poster

Authors

null

Matthew Krebs

Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom

Matthew Krebs , Melissa Lynne Johnson , Byoung Chul Cho , Keunchil Park , Nahor Haddish-Berhane , Donna Zemlickis , Anna Mitselos , Francis Meacle , Roland Elmar Knoblauch , Peter Hellemans , Anna Rachel Minchom

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Track

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Sub Track

Pharmacology/Pharmacodynamics/Pharmacogenetics

Clinical Trial Registration Number

NCT04606381

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr TPS3150)

DOI

10.1200/JCO.2021.39.15_suppl.TPS3150

Abstract #

TPS3150

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Anna Rachel Minchom

First Author: Funda Meric-Bernstam

First Author: Alison M. Schram

First Author: Vivek Subbiah